Yoshiaki Atsuta
Asahikawa Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshiaki Atsuta.
Journal of Immunology | 2000
Naoko Aoki; Shoji Kimura; Yumi Takiyama; Yoshiaki Atsuta; Asami Abe; Keisuke Sato; Makoto Katagiri
DAP12 is a recently cloned, immunoreceptor tyrosine-based activation motif-bearing transmembrane adapter molecule that is associated with the NK-activating receptors. Previous reports showed that the DAP12 message could be detected not only in NK cells but also in granulocytes, monocytes, dendritic cells, and macrophages. In this study we found a significant level of DAP12 protein expression in macrophage-related cell lines and organs. Additionally, we observed increased expression of DAP12 after LPS-induced differentiation of M1 cells into macrophages. To examine the role of DAP12 in the myeloid cell lineage, we established M1 FLAG-DAP12 transfectants (FDAP-M1) and demonstrated the marked morphological changes in FDAP-M1 cells caused by signaling through DAP12. Cell surface phenotypic analysis showed up-regulation of macrophage markers CD11b, 2.4G2, and adhesion molecule B7-2. Additionally, after stimulation through DAP12, phosphorylated FLAG -DAP12 could be immunoprecipitated using anti-phosphotyrosine mAbs. Collectively, these findings indicate that direct DAP12 signaling has an important role in macrophage differentiation.
American Journal of Pathology | 2003
Hitoshi Nochi; Naoko Aoki; Kensuke Oikawa; Mitsuru Yanai; Yumi Takiyama; Yoshiaki Atsuta; Hiroya Kobayashi; Keisuke Sato; Masatoshi Tateno; Takeo Matsuno; Makoto Katagiri; Zhou Xing; Shoji Kimura
DAP12 (also known as KARAP) is a novel ITAM-bearing transmembrane adapter molecule that is expressed on the cell surface of natural killer cells, monocytes, dendritic cells, and macrophages. Several myeloid cell-specific DAP12-associating receptors, such as TREM receptor family, SIRP-beta1, and MDL-1 have been identified. The in vivo function of DAP12 and its associating molecules in inflammation has remained primarily unknown. To investigate DAP12 signaling during chronic inflammation, we constructed two adenoviral gene transfer vectors to express FLAG/DAP12 (Ad-FDAP12) and the extracellular domain of mouse TREM-1 and the Fc portion of human IgG1 (Ad-TREM-1 Ig), respectively, and observed their modulatory activities in a mouse model of hepatic granulomatous inflammation elicited by zymosan A. Mice were injected with zymosan A intravenously and 24 hours after zymosan A, they were injected with Ad-FDAP12 or Ad-TREM-1 Ig. Zymosan A-induced hepatic granuloma formation peaked at day 7 and markedly declined by day 10. Although adenoviral-mediated DAP12 gene transfer did not enhance granuloma formation by day 7, it sustained and enhanced granuloma formation beyond day 7. However, an anti-FLAG monoclonal antibody used to potentiate the signaling of adenoviral-derived DAP12, enhanced granuloma formation at day 7. In sharp contrast to the effect by Ad-FDAP12, transgene expression in the liver of soluble form of extracellular domain of TREM-1 as an antagonist of DAP12 signaling, remarkably inhibited zymosan A-induced granuloma formation at all time points examined. Our findings thus suggest that both DAP12 and TREM-1 are involved in the development of granulomatous responses in the liver.
Journal of Dermatological Science | 2001
Hidetoshi Takahashi; Yoshiaki Atsuta; Katsuhiko Sato; Akemi Ishida-Yamamoto; Hiroshi Suzuki; Hajime Iizuka
Dariers disease (DD) is a rare, dominantly inherited skin disorder with abnormal keratinization and acantholysis. Recently, mutations of ATP2A2 encoding the sarco/endoplasmic reticulum Ca(2+)-ATPase type 2 isoform (SERCA2) have been reported in Caucasian DD families. In the present study, we examined the ATP2A2 gene mutations of three sporadic (AS1,AS3,AS4) and one familial (AS2) Japanese DD patients. Sequence analysis revealed that the patients had novel mutations, one nonsense mutation (AS1 (C613X)) and three single base changes leading to amino acid substitutions (AS2 (L321F), AS3 (I274V), and AS4 (M719I)). These results demonstrate that distinct ATP2A2 gene mutations are present in Japanese DD patients.
Cancer Letters | 2002
Yoshiaki Atsuta; Naoko Aoki; Keisuke Sato; Kensuke Oikawa; Hitoshi Nochi; Naoyuki Miyokawa; Satoshi Hirata; Shoji Kimura; Tadahiro Sasajima; Makoto Katagiri
The immunological screening of breast cancer was performed with IgG autoantibodies by the serological analysis of recombinant cDNA expression library methods to explore novel tumor associated antigens. We have focused on a small zinc finger protein metallopanstimulin-1 (MPS-1). MPS-1 mRNA was ubiquitously expressed in normal human tissues except the brain and the placenta. In Western blot analysis, MPS-1 was easily detected strongly in actively proliferating cells and three breast cancer cell lines. In the tissue the protein of MPS-1 in cancer cells was more abundant than that of surrounding normal cells. Screening of tissue specimens by immunohistochemistry revealed 50.4% positive for MPS-1 in 125 cancer patients. These data suggest that MPS-1 could be applicable to the immunotherapy of breast cancer.
Surgery Today | 2003
Yoshiaki Atsuta; Masashi Inaba; Kazutomo Goh; Nobuyoshi Azuma; Nobuyuki Akasaka; Hidenori Asada; Hisashi Uchida; Yoshihiko Tokusashi; Naoyuki Miyokawa; Tadahiro Sasajima
Fibromuscular dysplasia (FMD) can develop in many different arteries, but iliac artery aneurysms are rare. A 69-year-old Japanese woman was admitted to our hospital for treatment of a right common iliac artery aneurysm. Aortography revealed aneurysms in both the right common iliac artery and the left internal iliac artery. Notably, the right common iliac artery aneurysm had a “string-of-beads” appearance. At surgery, the aneurysms were resected, and replaced with Y-shaped vascular prostheses. The histopathological diagnosis was fibromuscular dysplasia (FMD). We report this case of common iliac artery aneurysm caused by FMD due to its rarity.
Journal of Biological Chemistry | 2004
Kensuke Oikawa; Shoji Kimura; Naoko Aoki; Yoshiaki Atsuta; Yumi Takiyama; Toshihiro Nagato; Mitsuru Yanai; Hiroya Kobayashi; Keisuke Sato; Tadahiro Sasajima; Masatoshi Tateno
Biochemical and Biophysical Research Communications | 2002
Naoko Aoki; Shoji Kimura; Kensuke Oikawa; Hitoshi Nochi; Yoshiaki Atsuta; Hiroya Kobayashi; Keisuke Sato; Makoto Katagiri
Japanese Circulation Journal-english Edition | 2007
Nobuyoshi Azuma; Nobuyuki Akasaka; Hidenori Asada; Takayuki Kadohama; Yoshiaki Atsuta; Keiko Kiyokawa; Tadahiro Sasajima
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2006
Taiichiro Shibaki; Yoshiaki Atsuta; Norio Morimoto
脈管学 | 2005
Masae Haga; Masashi Inaba; Nobuyoshi Azuma; Nobuyuki Akasaka; Takayuki Kadohama; Yoshiaki Atsuta; Akira Nagamine; Keijirou Mitsube; Tadahiro Sasajima